Epalrestat - CAS 82159-09-9

Epalrestat (ONO2235), an aldose reductase inhibitor, is well tolerated in Long-term therapy. It can effectually ameliorate the associated symptoms of diabetic neuropathy and delay the progression of the disease, particularly in patients with limited microangiopathy and good glycemic control.

Reductase

Endocrinology/Hormones, Metabolism

82159-09-9

0.9954

C15H13NO3S2

319.4

CC(=C/C1=CC=CC=C1)\C=C1/SC(=S)N(CC(O)=O)C1=O

-20°C

Ice Packs

Small Compound